MYLOTARG FDA approval date

The FDA approved MYLOTARG on 1 Sep 2017.

FDA approval date
1 Sep 2017

Drug identity has not yet been verified against registry records

Also recorded as GEMTUZUMAB OZOGAMICIN

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-09-01DayMYLOTARGFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761060", "applicant_as_listed_by_fda": "WYETH PHARMS INC", "brand_names": ["MYLOTARG"], "active_ingredients": ["GEMTUZUMAB OZOGAMICIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170901", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026